Presynaptic GluN2D containing NMDARs on CA1 Shaffer collateral terminals control the release of glutamate onto pyramidal cells
The Journal of Physiology · 2026-11-17
DOI: 10.1113/jp291838 ↗At a glance
Journal article in The Journal of Physiology, published online on 2026-11-17. Written by Tue G Banke and 7 co-authors. Institution: Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA. 43 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIH HHS, NIH/ORIP Emory National Biomedical Research Center, National Institutes of Health.
Abstract (original language)
NMDA receptors (NMDARs) are expressed throughout the brain and, in addition to their central role in synaptic transmission, are essential mediators of many forms of synaptic plasticity. Given their widespread expression, it is not surprising that NMDAR dysfunction has been implicated in numerous neurological and neuropsychiatric disorders, including epilepsy, autism spectrum disorders and depression. NMDARs are localized at both pre‐ and postsynaptic sites, but presynaptic NMDARs are poorly understood. Here, by combining the use of wild‐type and NMDAR subunit‐specific knockout mice, a series of highly selective subunit‐specific pharmacological modulators, and electron microscopy analysis of immunostained brain sections, we describe GluN2D‐containing NMDARs located presynaptically on CA3 pyramidal neuron axon terminals. We show that presynaptic NMDARs at the Schaffer collateral terminals control the probability of glutamate release onto connecting CA1 pyramidal neurons, but not Schaffer innervation of radiatum interneurons. Thus, GluN2D‐containing NMDARs could be involved in various forms of plasticity. image Key points Functional presynaptic NMDA receptors (NMDARs) are present on CA3 pyramidal cell presynaptic terminals synapsing onto pyramidal cells Presynaptic NMDARs contain GluN2D and GluN2B subunits Activation of presynaptic GluN2D‐containing NMDARs enhances the probability of vesicular release of glutamate Presynaptic GluN2D‐containing NMDARs regulate short‐term plasticity
Subjects
Author keywords
Authors and institutions
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Emory National Biomedical Research Center, Emory University, Atlanta, Georgia, USA.
- Department of Cell Biology, Emory University School of Medicine, Atlanta, Georgia, USA.
- Department of Chemistry, Emory University, Atlanta, Georgia, USA.
- Department of Cellular and Molecular Medicine, Florida International University, Miami, Florida, USA.
- Department of Neurology, Emory University, Atlanta, Georgia, USA.
ORCID profiles: Tue G Banke, Viktor J Olah, Matthew J M Rowan, Stephen F Traynelis
Funding
- NIH HHS
- NIH/ORIP Emory National Biomedical Research Center
- National Institutes of Health
Cite
APA
Banke, T. G., Pare, J. F., Olah, V. J., Akins, N. S., Rowan, M. J. M., Liotta, D. C., Smith, Y., & Traynelis, S. F. (2026). Presynaptic GluN2D containing NMDARs on CA1 Shaffer collateral terminals control the release of glutamate onto pyramidal cells. The Journal of Physiology. https://doi.org/10.1113/jp291838
Vancouver
Banke TG, Pare JF, Olah VJ, Akins NS, Rowan MJM, Liotta DC, et al. Presynaptic GluN2D containing NMDARs on CA1 Shaffer collateral terminals control the release of glutamate onto pyramidal cells. The Journal of Physiology. 2026. doi:10.1113/jp291838
BibTeX
@article{Banke2026,
author = {Banke, Tue G and Pare, Jean-Francois and Olah, Viktor J and Akins, Nick S and Rowan, Matthew J M and Liotta, Dennis C and Smith, Yoland and Traynelis, Stephen F},
title = {Presynaptic GluN2D containing NMDARs on CA1 Shaffer collateral terminals control the release of glutamate onto pyramidal cells},
journal = {The Journal of Physiology},
year = {2026},
doi = {10.1113/jp291838}
}
EUVIMED